BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32311761)

  • 21. Comparison of proliferating cell nuclear antigen, thyroid transcription factor-1, Ki-67, p63, p53 and high-molecular weight cytokeratin expressions in papillary thyroid carcinoma, follicular carcinoma, and follicular adenoma.
    Tan A; Etit D; Bayol U; Altinel D; Tan S
    Ann Diagn Pathol; 2011 Apr; 15(2):108-16. PubMed ID: 21315633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytomorphologic overlap of differentiated thyroid carcinoma and lung adenocarcinoma and diagnostic value of TTF-1 and TGB on cytologic material.
    Sathiyamoorthy S; Maleki Z
    Diagn Cytopathol; 2014 Jan; 42(1):5-10. PubMed ID: 23637102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Papillary Thyroid Carcinoma Cervical Lymph Node Metastasis with Cystic Change Differentiated from Congenital Cystic Lesions with the Assistance of Immunohistochemistry: A Case Study.
    Liang Y; Zuo T
    Head Neck Pathol; 2017 Sep; 11(3):301-305. PubMed ID: 27770399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unusual sclerosing haemangiomas and sclerosing haemangioma-like lesions, and the value of TTF-1 in making the diagnosis.
    Nicholson AG; Magkou C; Snead D; Vohra HA; Sheppard MN; Goldstraw P; Beddow E; Hansell DM; Travis WD; Corrin B
    Histopathology; 2002 Nov; 41(5):404-13. PubMed ID: 12405908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histopathological patterns of papillary tumour of the pineal region.
    Matyja E; Grajkowska W; Nauman P; Bonicki W
    Folia Neuropathol; 2011; 49(3):181-90. PubMed ID: 22101951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is spindle cell oncocytoma a true entity or a variant of pituicytoma? A case report with review of literature.
    Gupta RK; Batra VV; Singh D; Sharma MC; Kumar V
    Neurol India; 2018; 66(5):1413-1418. PubMed ID: 30233016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinicopathologic characteristics of thyroid-like follicular carcinoma of the kidney: an analysis of five cases and review of literature].
    Chen X; Dou FX; Cheng XB; Guo AT; Shi HY
    Zhonghua Bing Li Xue Za Zhi; 2016 Oct; 45(10):687-691. PubMed ID: 27760609
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinicopathological and molecular implications of aberrant thyroid transcription factor-1 expression in colorectal carcinomas: an immunohistochemical analysis of 1319 cases using three different antibody clones.
    Bae JM; Kim JH; Park JH; Park HE; Cho NY; Kang GH
    Histopathology; 2018 Feb; 72(3):423-432. PubMed ID: 28914964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TTF1-positive Papillary Epithelial Tumor of Pituitary: An Epithelial Variant of Pituicytoma?
    Chatterjee D; Lath K; Radotra BD; Gupta AK; Singh P
    Appl Immunohistochem Mol Morphol; 2020 Jan; 28(1):e1-e5. PubMed ID: 31809313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pituicytoma: Review of commonalities and distinguishing features among TTF-1 positive tumors of the central nervous system.
    El Hussein S; Vincentelli C
    Ann Diagn Pathol; 2017 Aug; 29():57-61. PubMed ID: 28807344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ependymoma of the sella turcica: a variant of pituicytoma.
    Scheithauer BW; Swearingen B; Whyte ET; Auluck PK; Stemmer-Rachamimov AO
    Hum Pathol; 2009 Mar; 40(3):435-40. PubMed ID: 18992914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathological Features of Low-Grade Thyroid-like Nasopharyngeal Papillary Adenocarcinoma.
    Li M; Wei J; Yao X; Wang C
    Cancer Res Treat; 2017 Jan; 49(1):213-218. PubMed ID: 27384157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thyroid transcription factor-1, thyroglobulin, cytokeratin 7, and cytokeratin 20 in thyroid neoplasms.
    Bejarano PA; Nikiforov YE; Swenson ES; Biddinger PW
    Appl Immunohistochem Mol Morphol; 2000 Sep; 8(3):189-94. PubMed ID: 10981870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thyroid transcription factor 1 in pulmonary adenocarcinoma.
    Stenhouse G; Fyfe N; King G; Chapman A; Kerr KM
    J Clin Pathol; 2004 Apr; 57(4):383-7. PubMed ID: 15047742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyroid transcription factor-1 as a prognostic indicator for stage IV lung adenocarcinoma with and without EGFR-sensitizing mutations.
    Park JY; Jang SH; Kim HI; Kim JH; Park S; Hwang YI; Jung KS; Seo J; Lee CY; Ko Y; Park YB
    BMC Cancer; 2019 Jun; 19(1):574. PubMed ID: 31196060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thyroid-like low-grade nasopharyngeal papillary adenocarcinoma: report of two cases.
    Ohe C; Sakaida N; Tadokoro C; Fukui H; Asako M; Tomoda K; Uemura Y
    Pathol Int; 2010 Feb; 60(2):107-11. PubMed ID: 20398195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Choroid plexus papilloma originating in the sella turcica--case report.
    Sameshima T; Tanikawa R; Sugimura T; Izumi N; Seki T; Maeda T; Tsuboi T; Hashimoto M; Kimura T; Nabeshima K
    Neurol Med Chir (Tokyo); 2010; 50(2):144-6. PubMed ID: 20185881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Incidence of Labelling of Non-Lung Adenocarcinomas With Antibodies Against TTF-1 and Diagnostic Implications.
    Prabhakaran S; Woo WLW; Xing G; Moffat D; Hussey M; Henderson DW; Klebe S
    Appl Immunohistochem Mol Morphol; 2020 Jul; 28(6):471-476. PubMed ID: 31135446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Papillary thyroid carcinoma expressing CD20.
    Sasaki Y; Seto M; Miyoshi H; Okada S; Yokoyama S; Ohshima A; Ohshima K
    Pathol Int; 2017 Jul; 67(7):350-354. PubMed ID: 28618063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An immunohistochemical study of papillary tumors in the central nervous system.
    Ang LC; Taylor AR; Bergin D; Kaufmann JC
    Cancer; 1990 Jun; 65(12):2712-9. PubMed ID: 2187587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.